Convidado
HUSSEIN TAWBI
Professor and Deputy Chair of the the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center. Dr. Tawbi joined MD Anderson in 2015 and in addition to being a melanoma clinician, he develops and conducts multiple clinical trials with translational endpoints in melanoma and immunotherapy. He also co-founded and co-directs the MD Anderson Brain Metastasis Clinic, a multi-disciplinary clinic to evaluate, treat, and develop novel therapeutic strategies for patients with brain metastases.
Atividades
15/09/2023
12:00 às 13:00 - Simpósio Satélite - Adjuvant Melanoma: Treatment & Adverse Events Management Algorithm
Palestrante
16/09/2023
08:35 às 12:00 - MÓDULO IMUNO-ONCOLOGIA
10:15 às 10:35 - Anti-PD1 alone vs Ipi/Nivo vs Relatlimab/Nivo as first line. How to choose among these options?
Palestrante
16/09/2023
08:35 às 12:00 - MÓDULO IMUNO-ONCOLOGIA
10:35 às 10:55 - How to treat patients who fail antiPD1 alone as first line therapy?
Palestrante
